EE345 Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Abstract
Authors
Massimiliano Povero Lorenzo Pradelli Matteo Pinciroli Giorgio Ghignoni